BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 33858474)

  • 1. Current status and recent advances in resection cavity irradiation of brain metastases.
    Minniti G; Niyazi M; Andratschke N; Guckenberger M; Palmer JD; Shih HA; Lo SS; Soltys S; Russo I; Brown PD; Belka C
    Radiat Oncol; 2021 Apr; 16(1):73. PubMed ID: 33858474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone.
    Patel KR; Prabhu RS; Kandula S; Oliver DE; Kim S; Hadjipanayis C; Olson JJ; Oyesiku N; Curran WJ; Khan MK; Shu HK; Crocker I
    J Neurooncol; 2014 Dec; 120(3):657-63. PubMed ID: 25189789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Whole Brain Radiation Therapy in Adults With Newly Diagnosed Metastatic Brain Tumors.
    Gaspar LE; Prabhu RS; Hdeib A; McCracken DJ; Lasker GF; McDermott MW; Kalkanis SN; Olson JJ
    Neurosurgery; 2019 Mar; 84(3):E159-E162. PubMed ID: 30629211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases.
    Do L; Pezner R; Radany E; Liu A; Staud C; Badie B
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):486-91. PubMed ID: 18922650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): study protocol for a randomized phase III trial.
    Waltenberger M; Bernhardt D; Diehl C; Gempt J; Meyer B; Straube C; Wiestler B; Wilkens JJ; Zimmer C; Combs SE
    BMC Cancer; 2023 Jul; 23(1):709. PubMed ID: 37516835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
    Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
    Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection.
    Bilger A; Bretzinger E; Fennell J; Nieder C; Lorenz H; Oehlke O; Grosu AL; Specht HM; Combs SE
    Cancer Med; 2018 Jun; 7(6):2350-2359. PubMed ID: 29745035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.
    Karlovits BJ; Quigley MR; Karlovits SM; Miller L; Johnson M; Gayou O; Fuhrer R
    Neurosurg Focus; 2009 Dec; 27(6):E7. PubMed ID: 19951060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.
    Linskey ME; Andrews DW; Asher AL; Burri SH; Kondziolka D; Robinson PD; Ammirati M; Cobbs CS; Gaspar LE; Loeffler JS; McDermott M; Mehta MP; Mikkelsen T; Olson JJ; Paleologos NA; Patchell RA; Ryken TC; Kalkanis SN
    J Neurooncol; 2010 Jan; 96(1):45-68. PubMed ID: 19960227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: prospective evaluation of target margin on tumor control.
    Choi CY; Chang SD; Gibbs IC; Adler JR; Harsh GR; Lieberson RE; Soltys SG
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):336-42. PubMed ID: 22652105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic radiosurgery versus whole-brain radiotherapy after intracranial metastasis resection: a systematic review and meta-analysis.
    Lamba N; Muskens IS; DiRisio AC; Meijer L; Briceno V; Edrees H; Aslam B; Minhas S; Verhoeff JJC; Kleynen CE; Smith TR; Mekary RA; Broekman ML
    Radiat Oncol; 2017 Jun; 12(1):106. PubMed ID: 28646895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size.
    Hartford AC; Paravati AJ; Spire WJ; Li Z; Jarvis LA; Fadul CE; Rhodes CH; Erkmen K; Friedman J; Gladstone DJ; Hug EB; Roberts DW; Simmons NE
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):650-5. PubMed ID: 22795806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative stereotactic radiosurgery for resected brain metastases: A comparison of outcomes for large resection cavities.
    Zhong J; Ferris MJ; Switchenko J; Press RH; Buchwald Z; Olson JJ; Eaton BR; Curran WJ; Shu HG; Crocker IR; Patel KR
    Pract Radiat Oncol; 2017; 7(6):e419-e425. PubMed ID: 28668668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic Radiosurgery for Postoperative Metastatic Surgical Cavities: A Critical Review and International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines.
    Redmond KJ; De Salles AAF; Fariselli L; Levivier M; Ma L; Paddick I; Pollock BE; Regis J; Sheehan J; Suh J; Yomo S; Sahgal A
    Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):68-80. PubMed ID: 33891979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced Mortality and Radiation Necrosis After Surgery With Postoperative Stereotactic Radiation in Patients With Multiple Brain Metastases.
    Bhave VM; Lamba N; Tjong MC; Aizer AA; Bi WL
    Neurosurgery; 2024 Jan; 94(1):117-128. PubMed ID: 37489905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase III, multicenter, randomized controlled trial of preoperative versus postoperative stereotactic radiosurgery for patients with surgically resectable brain metastases.
    Das S; Faruqi S; Nordal R; Starreveld Y; Kelly J; Bowden G; Amanie J; Fairchild A; Lim G; Loewen S; Rowe L; Wallace C; Ghosh S; Patel S
    BMC Cancer; 2022 Dec; 22(1):1368. PubMed ID: 36585629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Stereotactic Radiotherapy of the Resection Cavity After Surgery of Brain Metastases Compared to Postoperative Whole-Brain Radiotherapy (ESTRON)-A Single-Center Prospective Randomized Trial.
    El Shafie RA; Paul A; Bernhardt D; Hauswald H; Welzel T; Sprave T; Hommertgen A; Krisam J; Schmitt D; Klüter S; Schubert K; Klose C; Kieser M; Debus J; Rieken S
    Neurosurgery; 2018 Sep; 83(3):566-573. PubMed ID: 29528419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.
    Tsao MN; Lloyd N; Wong RK; Chow E; Rakovitch E; Laperriere N; Xu W; Sahgal A
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003869. PubMed ID: 22513917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.